Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Point Of Care Lipid Test Market’s size between 2026 and 2030?
The point of care lipid test market size has experienced significant expansion in recent years. It is anticipated to increase from $0.74 billion in 2025 to $0.82 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. This growth witnessed during the historic period can be ascribed to factors such as the increasing occurrence of cardiovascular diseases, the necessity for swift diagnostic methods, developments in biosensor technology, heightened awareness regarding cholesterol management, and the accessibility of point-of-care devices.
The point of care lipid test market size is projected to experience substantial expansion over the next few years. It is anticipated to reach $1.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. The increase during this forecast period can be attributed to the integration with mobile applications and cloud platforms, a rise in home care implementations, broader adoption in clinics and hospitals, the ongoing development of multi-analyte tests, and collaborations between device and software providers. Noteworthy trends for the forecast period include fingerstick lipid testing, the use of portable lipid analyzers, multi-parameter analyzers, rapid cardiovascular risk assessments, and home-based lipid monitoring.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28300&type=smp
Which Drivers Are Shaping Strategic Decisions In The Point Of Care Lipid Test Market?
The increasing incidence of cardiovascular diseases is set to drive the expansion of the point of care lipid test market. Cardiovascular diseases encompass disorders of the heart and blood vessels, including coronary artery disease, stroke, and hypertension, frequently caused by atherosclerosis associated with abnormal cholesterol and triglyceride levels. The rising occurrence of these diseases is linked to growing sedentary lifestyles and decreased physical activity, which contribute to obesity, poor circulation, and other risk factors for CVDs. Point-of-care lipid tests play a vital role in addressing this escalating prevalence by enabling rapid, on-site measurement of cholesterol and other lipid levels, facilitating early risk identification and swift treatment decisions to prevent disease worsening. For example, in January 2024, the American Heart Association, a US-based nonprofit organization, reported that deaths from cardiovascular disease reached 931,578, representing an increase of 3,000 fatalities compared to the previous year’s figure of 928,741. Thus, the growing prevalence of cardiovascular diseases is expected to propel the growth of the point of care lipid test market.
What Segment Classifications Make Up The Point Of Care Lipid Test Market?
The point of care lipid test market covered in this report is segmented –
1) By Product Types: Instruments, Consumables
2) By Application: Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Familial Hypercholesterolemia, Other Applications
3) By End-User: Hospitals, Clinics, Home Care Settings, Other End Users
Subsegments:
1) By Instruments: Portable Or Handheld Analyzers, Multi-parameter Analyzers, Single-parameter Analyzers
2) By Consumables: Test Strip, Reagents And Kits
Which Market Trends Are Opening Growth Opportunities In The Point Of Care Lipid Test Market?
Companies in the point-of-care lipid test market are concentrating on innovative solutions, notably advanced point-of-care (POC) diagnostic platforms, to offer rapid, accurate, and lab-quality lipid panel results at the patient’s bedside, which enhances clinical decision-making and patient management. An advanced point-of-care (POC) diagnostic platform refers to a portable, integrated device capable of performing quick, precise, and laboratory-standard tests near the patient, thereby enabling real-time clinical choices and immediate health management. For example, in July 2023, Vital Biosciences Inc., a Canada-based health technology company, introduced VitalOne, a point-of-care lab testing platform developed to provide over 50 lab-grade blood test results in just 20 minutes using a compact, automated device in settings like clinics and pharmacies. This system unifies hematology, clinical chemistry, and immunoassays within a single instrument, allowing healthcare providers to conduct testing, diagnosis, and treatment during one visit, significantly improving access, speed, and personalization of patient care, all while maintaining accuracy equivalent to traditional central labs.
Which Leading Companies Dominate The Point Of Care Lipid Test Market Share?
Major companies operating in the point of care lipid test market are Abbott Laboratories, EKF Diagnostics Holdings plc, Roche Diagnostics International AG, Siemens Healthineers AG, Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, EKF Diagnostics USA Inc., VivaChek Biotech (Hangzhou) Co. Ltd., Menarini Diagnostics S.r.l., Trinity Biotech plc, AccuBioTech Co. Ltd., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited, SD Biosensor Inc., ARKRAY Inc., PTS Diagnostics, HemoCue AB, MedTest Dx Inc., Nova Biomedical Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/point-of-care-lipid-test-global-market-report
Which Region Is Anticipated To See The Fastest Growth In The Point Of Care Lipid Test Market?
North America was the largest region in the point of care lipid test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care lipid test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Point Of Care Lipid Test Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28300&type=smp
Browse Through More Reports Similar to the Global Point Of Care Lipid Test Market 2026, By The Business Research Company
Low Density Lipoprotein Test Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/low-density-lipoprotein-test-global-market-report
Lipid Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/lipid-global-market-report
Cholesterol Test Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company